DNB Carnegie | Back Bay Partnership

A unique integrated strategy and corporate and investment banking solution for global and emerging healthcare companies.

The DNB Carnegie | Back Bay Partnership strengthens companies with financial and strategic guidance on growth opportunities across sector and development stage. We are a committed partner throughout the development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on U.S. and Nordic exchanges.

Get in touch (e-mail)

Partnership Capabilities/Offerings

Strategy

Strategic advice based on nuanced understanding of the clinical and scientific foundations of new therapeutics and medical technologies, expertise in business and financial markets, and knowledge of what makes successful R&D, commercialization and transactions. The Partnership provides actionable strategies for product development, commercial success and transactional execution to drive growth and investment returns

Debt Capital Markets

Resources

Equity Capital Markets

Mergers and Acquisitions

Analyst reports

The DNB Carnegie | Back Bay Partnership publishes industry reports on the healthcare sector. Reports are authored by Back Bay Life Science Advisors’ experts on global life science development and DNB Carnegie's senior analysts. Subscribe here via e-mail.

The Multispesific Moment - Biological trends in drug development (PDF, file.anchor.en.label)Open the file in a new tab

CNS therapeutic development (PDF)Open the file in a new tab

Obesity drug development (PDF)Open the file in a new tab

Markets update

Our weekly bulletin shares healthcare IPOs, follow-on offerings, M&A, and venture financing activity across the US and EU.

Read weekly markets update here

NAHC New York City skyline New Jersey over Hudson River

Nordic-American Healthcare

A conference uniting top U.S. and Nordic life science companies for in-depth healthcare discussions and presentations.

About the Partnership

The DNB Carnegie | Back Bay Partnership was formalized to drive global healthcare growth and innovation. The Partnership provides a full range of strategic advisory and financing capabilities along the full continuum of life science and healthcare company development.

DNB Carnegie headquartered in Oslo, Norway, and Back Bay Life Science Advisors, headquartered in Boston, Massachusetts, are recognized leaders in global life science development and banking. Together we have a unique position bridging the Nordic and US markets.

The DNB Carnegie | Back Bay Partnership, is a marketing term referring to a strategic agreement between DNB Carnegie, Inc. and Back Bay Life Science Advisors, please see below for more information about DNB Carnegie and Back Bay.

About

DNB and DNB Carnegie

DNB Carnegie is the Nordic’s largest financial institution and leading corporate and investment bank, with international expertise in corporate banking and public capital markets across selected industry sectors, specializing in arranging financing for healthcare companies globally.

The DNB Group has been established in North America since 1975, with a full service branch in New York that serves corporate customers in the bank’s strategic business areas. A full range of investment banking services are provided by DNB Carnegie*.

*Securities products and services are offered in the U.S. through DNB Carnegie, Inc., a U.S. registered broker-dealer and a separately incorporated subsidiary of DNB Bank ASA. DNB Carnegie, Inc. is a member of the Financial Industry Regulatory Authority (“FINRA”) and the Securities Investor Protection Corporation (“SIPC”). Securities products and services are offered in the European Economic Area through DNB Carnegie, a division of DNB Bank ASA

Back Bay Life Science Advisors

Back Bay Life Science Advisors (Back Bay) provides life science strategy and investment banking guidance and execution to global life science companies and their investors. Back Bay’s integrated strategy and banking teams advise companies on all aspects of life science, healthcare technology and drug development, including planning an initial concept, product commercialization, franchise growth, licensing, partnering, M&A, divestiture and more.

With a strong presence in Europe and the Nordic markets and a global reach, Back Bay has guided hundreds of healthcare companies through the complexities of commercial development and transactions. Every project and transaction is rooted in Back Bay’s deep expertise in life science, healthcare industry strategy and investment banking. Learn more:www.bblsa.com

Contact information

The DNB Carnegie | Back Bay Partnership is comprised of dedicated multidisciplinary teams of healthcare experts and corporate and investment bankers

Send us an e-mail

DNB Carnegie | Back Bay Partnership disclosure

Read our disclosures for Marketing Material Use including new business decks to clients, analyst/bb white papers, ECM updates, web pages, etc

To the full disclosure